Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_assertion type Assertion NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_head.
- NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_assertion wasGeneratedBy ECO_0000203 NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_provenance.
- NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_assertion wasDerivedFrom befree-2016 NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_provenance.
- NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_assertion SIO_000772 19864236 NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_provenance.
- NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_assertion evidence source_evidence_literature NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_provenance.
- NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_assertion description "[Our results from a large series of Chinese patients with breast cancer support that the ASCO/CAP 30% criterion may offer better results for assessing HER2 status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772289.RA2eSv_5ckRgMCI1GZR6ytRWKVM-ocYkwyubswV4cO1CY130_provenance.